Chimeric Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '24 Sep 5, 2024	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020
Market Capitalization	5	12	13	27	72	-
Market Cap Growth	-60.60%	-8.78%	-52.46%	-62.53%	-	-
Enterprise Value	2	9	10	18	76	-
Last Close Price	0.00	0.03	0.01	-	-	-
PS Ratio	4.13	2.35	4.27	14.95	-	-
PB Ratio	1.42	7.09	3.40	1.52	3.82	-
P/TBV Ratio	-	-	-	3.25	8.49	-
EV/Sales Ratio	1.52	1.88	3.47	9.82	-	-
Debt / Equity Ratio	-	-	-	-	-	-0.53
Asset Turnover	0.09	0.40	0.16	0.07	-	-
Quick Ratio	0.69	0.31	0.61	2.33	3.05	0.00
Current Ratio	0.70	0.32	0.64	2.35	3.08	0.00
Return on Equity (ROE)	-180.09%	-308.21%	-165.25%	-62.55%	-120.59%	-
Return on Assets (ROA)	-48.71%	-44.03%	-54.54%	-25.52%	-50.84%	-
Return on Capital (ROIC)	-111.60%	-203.88%	-99.55%	-35.83%	-73.94%	-
Earnings Yield	-211.67%	-71.52%	-134.60%	-40.63%	-15.75%	-
FCF Yield	-	-43.02%	-84.69%	-33.65%	-9.22%	-
Buyback Yield / Dilution	-84.50%	-60.57%	-20.37%	-97.88%	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.